
April 29, 2025 is National AMKD Awareness Day
The American Kidney Fund is leading efforts to raise awareness about APOL1-Mediated Kidney Disease (AMKD). Be APOL1 kidney aware on April 29 and year-round.

What is AMKD?
APOL1-Mediated Kidney Disease (AMKD) is a spectrum of kidney diseases associated with mutations in the apolipoprotein L1 (APOL1) gene that is linked to an increased risk for rapidly progressing kidney disease in people of Western and Central African descent.
Join the APOL1 community
Thank you for your interest and support of AMKD Awareness Day, which will be observed on April 29, 2025. If you or your organization would like to get involved, please fill out this form.
Sign up below:

Be APOL1 aware
Being APOL1 aware means knowing how your genes impact your kidney health. Knowing whether you have the APOL1 variants that cause AMKD could keep your kidneys working longer. The only way to know is to have a genetic test.
Resources for Kidney Professionals
In addition to the genetic counseling guide available for your patients, AKF's webinar provides an overview of on APOL1-mediated kidney disease and implications for patient care and accompanying summary are available for health care professionals.
AMKD stories
AKF is working to collect personal AMKD stories to illustrate the patient journey and draw attention to this disease.
State Proclamations
Proclamations help bring public attention and inform elected officials about a wide number of issues.
AMKD Awareness Day supporters
Thank you to all of the organizations who supported this year's efforts to raise much-needed awareness of AMKD.